Effects of a Isokinetic Exercise in Women With Fibromyalgia (NCT07483216) | Clinical Trial Compass
RecruitingNot Applicable
Effects of a Isokinetic Exercise in Women With Fibromyalgia
Spain36 participantsStarted 2026-04
Plain-language summary
Fibromyalgia is a chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and functional impairment, which significantly affects quality of life. Physical exercise is considered one of the most effective non-pharmacological interventions for the management of this condition; however, uncertainty remains regarding the most appropriate type, intensity, and frequency of exercise for different patient profiles. The aim of this study is to analyze the effects of a microdoses isokinetic exercise program on physical condition, perceived pain, inflammatory profile and quality of life in women diagnosed with fibromyalgia.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women aged ≥ 18 years diagnosed with fibromyalgia according to current clinical criteria.
* Clinical and pharmacological stability during the weeks prior to participation in the study.
* Ability to perform supervised exercise and to complete the assessments.
* Written informed consent.
Exclusion Criteria:
* Cardiovascular, neurologic, musculoskeletal or systemic pathology that contraindicate the performance of exercise.
* Significant change in pharmacological treatment during the period immediately preceding the study.
* Any condition that, in clinical judgement, prevents them from following the protocol safely.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Peak torque
Timeframe: Baseline, up to study completion (8 weeks); week 9
2
Peak torque
Timeframe: Baseline, up to study completion (8 weeks); week 9
3
Agonist-antagonist ratio
Timeframe: Baseline, up to study completion (8 weeks); week 9
4
Total work
Timeframe: Baseline, up to study completion (8 weeks); week 9.